- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01776034
Health Promotion and Wellness Program for Adults With Disabling Conditions
January 18, 2022 updated by: Matthew Plow, Case Western Reserve University
Examining the Efficacy of a SystemCHANGE™ Weight Management Intervention in Stroke Survivors and Persons With Chronic Inflammatory Autoimmune/Immune-mediated Diseases
The objective of this study is to conduct a randomized controlled pilot study to examine the efficacy, feasibility and safety of the SystemCHANGE™(SC) health promotion and wellness program in adults with disabling conditions.
Particularly, the study will focus on developing a program of research on adapting and testing SC weight management interventions in overweight and obese stroke survivors and persons with chronic inflammatory autoimmune/immune-mediated diseases, specifically those with multiple sclerosis (MS) and rheumatoid arthritis (RA).
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Individuals with disabling conditions, such as stroke, multiple sclerosis, or rheumatoid arthritis, face many barriers to engaging in physical activity, healthy nutritional habits, and good sleep hygiene.
This leads to weight gain, de-conditioning, and declines in upper- and lower- extremity function, which makes it even more difficult to engage in healthy behaviors, thereby perpetuating a cycle of functional decline.
Developing an effective weight management intervention may be a strategy for disrupting this disabling cycle and reducing the impact of the disease.
Fostering a positive social environment may help adults with disabling conditions overcome barriers to engaging in healthy behaviors.
SystemCHANGE (SC) is a new behavior change program that uses approaches consistent with social ecological theories and process improvement techniques (i.e.
changing the dynamics of a system or group) to increase social support in lifestyle behaviors that promote energy balance.
SC focuses on redesigning the social environment using a series of trial-and-error "experiments", which is in contrast to cognitive-behavioral interventions that focus on changing a person's viewpoint of a situation and increasing motivation.
In a SC intervention, individuals are taught a set of skills to assist them in incorporating habitual lifestyle behaviors into their daily systems so they succeed despite wavering motivation.
The rationale for developing a weight management intervention for these patients is to slow disability progression and prevent secondary conditions.
Study Type
Interventional
Enrollment (Actual)
66
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Ohio
-
Cleveland, Ohio, United States, 44106
- Case Western Reserve University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
26 years to 71 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria Stroke:
- Physician-confirmed diagnosis of stroke (> 6 weeks)
- Body mass index between 23 to 45 kg/m2
- Age 30 to 75 years
Exclusion Criteria Stroke:
- Pregnant or plans to become pregnant in the next 6 months
- Current participation in a face-to-face weight management program
- Uncontrolled diabetes (hospitalization within the prior 6 months)
- Serious mental illness
- Thyroid and adrenal gland diseases
- Inability to walk 3 meters with or without a cane or walker
- Severe cardiopulmonary disease that limits engagement in physical activity (e.g., myocardial infarction, congestive heart failure, coronary artery bypass grafting or valve replacement during the past three months, serious cardiac arrhythmias, hypertrophic cardiomyopathy, severe aortic stenosis, and pulmonary embolus) or abnormal blood pressure or heart rate response after the 6-Minute Walking Test (e.g., a drop in systolic blood pressure of >10mmHg from baseline)
- Severe cognitive deficits (Screening questioanire called the Short Orientation Memory-Concentration < 12)
- Currently taking oral corticosteroids, antipsychotic (except for depression medication), or medications specifically for weight loss
- 3 or more falls in the past month
- Bulimia
- Unable to speak English over the phone
- Able to eat independently and is not on a special diet because of difficulty in swallowing
- Unstable weight (gained or lost >10lbs in the last two months)
Inclusion Criteria MS or RA:
- Physician-confirmed diagnosis of multiple sclerosis or rheumatoid arthritis
- Body mass index between 23 to 45 kg/m2
Exclusion Criteria MS or RA:
- Pregnant or plans to become pregnant in the next 6 months
- Current participation in a face-to-face weight management program
- Uncontrolled diabetes (hospitalization within the prior 6 months)
- Serious mental illness
- Inability to walk 3 meters with or without a cane or walker
- Severe cardiopulmonary disease that limits engagement in physical activity
- Severe cognitive deficits (Short Orientation Memory-Concentration < 12)
- Currently taking oral corticosteroids, antipsychotic (except for depression medication), or medications specifically for weight loss
- 3 or more falls in the past month
- Bulimia
- Unable to speak English
- Uncontrolled thyroid or adrenal disease (change in type and dosage of medication within the prior 3 months)
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: SystemCHANGE Group Lifestyle counseling
The SystemCHANGE™ intervention will be delivered over a six-month period involving 12 face-to-face group sessions (1.5 to 2 hours each) held weekly for three months, followed by three monthly "booster calls."
Intervention groups include ~10 to 15 patients, and friends and family members are encouraged to attend.
Intervention sessions consist of 30-min to 60-min of behavior change activities and 60-min focused on healthy behaviors.
|
|
|
Active Comparator: Phone Lifestyle Counseling
Participants will receive pamphlets that contain information on healthy eating, physical activity, sleep, and symptom management, and will be followed-up with telephone calls.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Changes from baseline in body weight.
Time Frame: Each patient will be given the assessments at 2 points during the study, at baseline and at posttest (an average of 6 months from baseline).
|
A digital scale will be used to measure Body weight.
|
Each patient will be given the assessments at 2 points during the study, at baseline and at posttest (an average of 6 months from baseline).
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Changes from baseline in cardiovascular risk biomarkers.
Time Frame: Each patient will be given the assessments at 2 points during the study, at baseline and at posttest (an average of 6 months from baseline).
|
The Alere Cholestech LDX 1 Analyzer will be used to measure Triglycerides levels.
|
Each patient will be given the assessments at 2 points during the study, at baseline and at posttest (an average of 6 months from baseline).
|
|
Changes from baseline in Walking Test.
Time Frame: Each patient will be given the assessments at 2 points during the study, at baseline and at posttest (an average of 6 months from baseline).
|
A Six Minute Walking Test will be administered using standardized instructions and verbal cues
|
Each patient will be given the assessments at 2 points during the study, at baseline and at posttest (an average of 6 months from baseline).
|
|
Changes from baseline in 1-minute sit to stand test
Time Frame: Each patient will be given the assessments at 2 points during the study, at baseline and at posttest (an average of 6 months from baseline).
|
A 1-minute sit to stand test will be administered using standardized instructions and verbal cues
|
Each patient will be given the assessments at 2 points during the study, at baseline and at posttest (an average of 6 months from baseline).
|
|
Changes from baseline Physical Activity
Time Frame: Each patient will be given the assessments at 2 points during the study, at baseline and at posttest (an average of 6 months from baseline).
|
Physical Activity and Disability Survey-Revised will be administered to assess physical function.
Higher scores on the Physical Activity and Disability Survey-Revised indicates increased physical activity levels.
Score range: Not applicable.
|
Each patient will be given the assessments at 2 points during the study, at baseline and at posttest (an average of 6 months from baseline).
|
|
Changes from baseline Self-efficacy for weight management
Time Frame: Each patient will be given the assessments at 2 points during the study, at baseline and at posttest (an average of 6 months from baseline).
|
Weight Efficacy Lifestyle Questionnaire-Short Form (WEL-SF) will be administered.
A higher score on the weight efficacy lifestyle questionnaire indicates more confidence to engage in a healthy behavior (possible score range for self-efficacy weight is 1 to 10)
|
Each patient will be given the assessments at 2 points during the study, at baseline and at posttest (an average of 6 months from baseline).
|
|
Changes from baseline social support for physical activity from family
Time Frame: Each patient will be given the assessments at 2 points during the study, at baseline and at posttest (an average of 6 months from baseline).
|
Social Support for Exercise Behavior scales will be administered.
A higher score on social support scales indicates greater social support from family to engage in physical activity (possible score range is 1 to 5).
|
Each patient will be given the assessments at 2 points during the study, at baseline and at posttest (an average of 6 months from baseline).
|
|
Changes from baseline in emotional well-being
Time Frame: Each patient will be given the assessments at 2 points during the study, at baseline and at posttest (an average of 6 months from baseline).
|
Quality of Life in Neurological Disorders (Neuro-Qol) positive affect & wellbeing questionnaires will be administered.
Higher scores on Quality of Life in Neurological Disorders (Neuro-Qol) positive affect and well-being indicates a greater life satisfaction (possible score range 9 to 45).
|
Each patient will be given the assessments at 2 points during the study, at baseline and at posttest (an average of 6 months from baseline).
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Matthew A Plow, PhD, Case Western Reserve University
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
January 1, 2013
Primary Completion (Actual)
December 1, 2016
Study Completion (Actual)
December 1, 2016
Study Registration Dates
First Submitted
January 23, 2013
First Submitted That Met QC Criteria
January 23, 2013
First Posted (Estimate)
January 25, 2013
Study Record Updates
Last Update Posted (Actual)
January 24, 2022
Last Update Submitted That Met QC Criteria
January 18, 2022
Last Verified
January 1, 2022
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 07-14-16 / 03-14-24
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Stroke
-
University of PittsburghRecruitingHemorrhagic Stroke | Embolic Stroke of Undetermined Source | Ischemic Stroke, Cryptogenic | Recurrent Ischemic Stroke | Ischemic Stroke, EmbolicUnited States
-
National Assembly ClinicBayero University Kano, NigeriaRecruitingStroke | Stroke Hemorrhagic | Stroke Ischemic | Hemiparesis After StrokeNigeria
-
Mahidol UniversityNot yet recruitingIschemic Stroke | Hemorrhagic Stroke | Subacute Stroke | Chronic Stroke SurvivorsThailand
-
Mahidol UniversityRecruitingIschemic Stroke | Hemorrhagic Stroke | Subacute Stroke | Chronic Stroke PatientThailand
-
University Hospital, GhentRecruitingStroke | Stroke, Ischemic | Stroke, Acute | Stroke Sequelae | Stroke HemorrhagicBelgium
-
Moleac Pte Ltd.Not yet recruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke, Cardiovascular | Strokes Thrombotic | Stroke, Embolic | Stroke, Cryptogenic
-
University of Illinois at ChicagoRecruitingStroke, Ischemic | Stroke Hemorrhagic | Stroke, CerebrovascularUnited States
-
IRCCS San Camillo, Venezia, ItalyRecruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke HemorrhagicItaly
-
Fondazione Don Carlo Gnocchi OnlusScuola Superiore Sant'Anna di Pisa; Fondazione Policlinico Universitario Campus...Not yet recruitingStroke | Stroke Hemorrhagic | Upper Limb Rehabilitation | Stroke IschemicItaly
-
Samsung Medical CenterCompletedChronic Stroke | Subacute Stroke | ExoskeletonSouth Korea
Clinical Trials on SystemCHANGE Group Lifestyle counseling
-
Mayo ClinicCompleted
-
Ajou University School of MedicineCompletedDietary Modification | Alteration of Cognitive Function
-
Instituto de Investigación Biomédica de SalamancaInstituto de Salud Carlos IIICompleted
-
Université de SherbrookeFonds de la Recherche en Santé du Québec; Diabetes QuébecCompletedGestational Diabetes | Excessive Weight Gain During PregnancyCanada
-
Fundacion para la Investigacion y Formacion en...Castilla-León Health ServiceCompleted
-
Brazilian National Cancer InstituteSuspendedObesity | Life Style | Endometrium CancerBrazil
-
Northwestern UniversityNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)CompletedHyperglycemia | Obesity | Diabetes MellitusUnited States
-
University of Toronto Practice Based Research NetworkCompletedHypertension | Type 2 DiabetesCanada
-
York UniversityPublic Health Agency of Canada (PHAC)Unknown
-
University of Kansas Medical CenterCompleted